Deepak Bhatt, MD, MPH, details long-term outcomes from the SYMPLICITY HTN-3 trial, which show a lasting impact on patients with uncontrolled hypertension. 

The new study, based on data from nearly 1,400 PAD patients who were treated with Shockwave Medical's IVL technology, was presented at VIVA22 in Las Vegas. 

Experts involved in the new research suggested that their findings are in line with that of conventional palliative radiotherapy

The American College of Cardiology and Heart Rhythm Society issued a joint statement soon after CMS published its final rule for the 2023 Medicare Physician Fee Schedule. The groups warned that the final rule could threaten patient access to high-quality care. 

The final rule updated the OPPS payment rate by 3.8% for calendar year 2023, which CMS based on the 4.1% projected hospital market basket percentage increase and adjusted for 0.3 percentage points for productivity. 

Physicians are now bracing for payment cuts after the Centers for Medicare and Medicaid Services (CMS) published its final rule for the 2023 Physician Fee Schedule.

“This was a true milestone for research on xenotransplantation," one specialist said. The full analysis is scheduled to be presented at the American Heart Association's Scientific Sessions 2022 in Chicago.

Medicare Advantage plans face little in the way of competition, and Medicare consumers are worse off for it, according to a new study from the American Medical Association.